BOSTON, MA / ACCESSWIRE / July 9, 2024 / AnnaBidiol, Inc., (OTC PINK:ACBD) (or the "Company"), is pleased to announce that it has entered into a Merger Agreement with Targatek, Inc., an AI Corporate Leadership SaaS Development Company. In the terms of the agreement, a reverse merger of Targatek Inc. will take place into a newly formed subsidiary of AnnaBidiol, Inc. that will result in the shareholders of Targatek receiving approximately 85% of the common stock of AnnaBidiol, Inc. after approximately 35,000,000 shares of common stock and 500,000 shares of Series A Preferred stock of AnnaBidiol, Inc., to be redeemed and canceled at closing.